Application of atractylenolide in preparation of antidepressant drug
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANXI UNIV
- Publication Date
- 2016-05-18
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The present invention relates to the application of atractylodes lactone, in particular to the application of atractylodes lactone in the preparation of antidepressant drugs. Background technique:
[0002] Depression is characterized by persistent low mood and cognitive dysfunction, including restlessness, anhedonia, sleep disturbance, guilt and repeated suicidal thoughts, etc. Disabling rate and high fatality rate and so on. The World Health Organization reports that more than 350 million people worldwide suffer from depression, and by 2020 depression may become the second leading disease after heart disease. With the rapid development of social economy, the pace of life is accelerated, people's pressure increases, and various emotional impacts increase, resulting in an increase in the incidence of depression year by year. Depression is called "the epidemic of the 21st century", and its harm has attracted more and more attention from the medical an...